Ogsiveo (nirogacestat tablets) — Cigna
Desmoid Tumors (Aggressive Fibromatosis)
Initial criteria
- Patient age ≥ 18 years; AND
- According to the prescriber, the patient has progressing desmoid tumors; AND
- Progressing desmoid tumors are defined as ≥ 20% progression within 12 months; AND
- The desmoid tumors are not amenable to surgery or radiotherapy; AND
- According to the prescriber, the patient requires systemic treatment
Approval duration
1 year